© Copyright 2025 American Medical Association. All rights reserved.
The CPT® Code 0130T refers to a specific type of clinical investigation that is conducted to evaluate the effectiveness of FDA-approved chronic care drugs. This procedure involves a validated and statistically reliable approach, ensuring that the findings are scientifically sound. The investigation is randomized and controlled, meaning that it includes a systematic method of assigning patients to different treatment groups to compare outcomes effectively. A key aspect of this procedure is that it is performed on a single patient, allowing for a focused assessment of the individual's response to the pharmaceutical treatment. The pharmacist plays a crucial role in this process by conducting the investigation and subsequently interpreting the results. The findings are then reported to the prescribing healthcare professional, providing them with valuable insights into the patient's reaction to the medication. This information is essential for managing chronic health conditions, as it helps healthcare providers make informed decisions regarding ongoing treatment plans and adjustments based on the patient's specific needs and responses.
© Copyright 2025 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 0130T is indicated for the evaluation of a patient's response to FDA-approved chronic care drugs. This investigation is particularly relevant for patients who are undergoing treatment for long-term health issues, where understanding the effectiveness and safety of the medication is critical. The following conditions may warrant the use of this procedure:
The procedure for CPT® Code 0130T involves several key steps that ensure a thorough investigation of the patient's response to the chronic care drug. Each step is designed to maintain the integrity and reliability of the study.
Post-procedure care following the investigation associated with CPT® Code 0130T involves monitoring the patient for any ongoing effects of the medication based on the findings of the study. The healthcare professional may need to adjust the patient's treatment plan according to the insights gained from the investigation. Additionally, follow-up appointments may be scheduled to reassess the patient's condition and response to the medication over time. It is essential for the healthcare provider to maintain open communication with the patient regarding any changes in their health status or concerns related to the medication. This ongoing evaluation ensures that the patient receives optimal care tailored to their specific needs.
| Short Descr | CHRON CARE DRUG INVESTIGATN | Medium Descr | 1-PT CHRNC CARE DRUGS INVSTGJ | Long Descr | CHRONIC CARE DRUG INVESTIGATION | Status Code | Carriers Price the Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x) | Type of Service (TOS) | 9 - Other Medical Items or Services | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 237 - Ancillary Services |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Deleted | Code deleted, to report use 99199 |
| 2006-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.